Cytotoxic bis-3,4-dihydro-β-carbolines and bis-β-carbolines

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 17, Issue 6, 2002, Pages 369-374

  Jiang, Wei Qun ^a   Charlet Fagnère, Catherine ^a   Sapi, Janos ^a   Laronze, Jean Yves ^a   Renard, Pierre ^b   Pfeiffer, Bruno ^b   Léonce, Stéphanie ^c  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^b ADIR   (France)

^c INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

Bis carboline; Bis 3,4 dihydro carboline; Cytotoxic activity

Indexed keywords

ANTINEOPLASTIC AGENT; BIS 3,4 DIHYDRO BETA CARBOLINE DERIVATIVE; BIS BETA CARBOLINE DERIVATIVE; CARBENOID; CARBOLINE DERIVATIVE; CARBON; CYTOTOXIC AGENT; UNCLASSIFIED DRUG;

ACYLATION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYCLIZATION; CYTOTOXICITY; DRUG SYNTHESIS; IC 50; LEUKEMIA L 1210; NONHUMAN; PRIORITY JOURNAL;

AMIDES; ANIMALS; CARBOLINES; CYCLIZATION; DRUG SCREENING ASSAYS, ANTITUMOR; INHIBITORY CONCENTRATION 50; LEUKEMIA L1210; MICE; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0036964553     PISSN: 14756366     EISSN: None     Source Type: Journal    
DOI: 10.1080/147563021000005631     Document Type: Article

References (22)

1. Noé, E., Séraphin, D., Zhang, Q., Djaté, F., Hénin, J., Laronze, J.Y and Lévy, J. (1996) "Synthesis of the new (cyclopenta[b]-pyrrolo[1,2-d])azepino[4,5-b]indole ring system", Tetrahedron Letters 37, 5701-5704.
2. For a review: "Bisnafide mesylate". Drugs of the Future, 21 (1996) 239-244.
3. Cholody, W.M., Hernandez, L., Hassner, L., Scudiero, D.A., Djurickovic, D.B. and Michejda, C.J. (1995) "Bisimidazoacridones and related compounds: new antineoplastic agents with high selectivity against colon tumors", Journal of Medicinal Chemistry 38, 3043-3052.
4. Denny, W.A., Gamage, S.A., Spicer, J.A., Baguley, B.C. and Graeme, J. (1998) "Bis(acridinecarboxamide) and bis(phenazinecarboxamide) as antitumor agents. Patent Cooperation Treaty International Application WO 98 17,650", Chemical Abstracts 128, 308499g.
5. Okahana, H., Tsuzuki, S., Mori, J. and Furukawa, H. (1994) "Preparation of pyridocarbazoles as neoplasm inhibitors. Japan Patent 06 80,668 [94 80,668]", Chemical Abstracts 121, 108767m.
6. Gregson, S.J., Howard, P.W., Hartley, J.A., Brooks, N.A., Adams, L.J., Jenkins, T.C., Kelland, L.R. and Thurston, D.E. (2001) "Design, synthesis, and evaluation of a novel pyrrolobenzodiazepine DNA-interactive agent with highly efficient cross-linking ability and potent cytotoxicity", Journal of Medicinal Chemistry 44, 737-748.
7. Gregson, S.J., Howard, P.W., Corcoran, K.E., Brooks, N.A., Jenkins, T.C., Kelland, L.R. and Thurston, D.E. (2001) "Synthesis of the first example of a C2-C3/C2′-C3′-endo unsaturated pyrrolo[2,1-c][1,4]benzodiazepine dimer", Bioorganic and Medicinal Chemistry Letters 11, 2859-2862.
8. Reddy, P.B.S., Damayanthi, Y. and Lown, W. (1999) "Design and efficient synthesis of novel DNA interstrand cross-linking agents: C-2 linked pyrrolo[2,1-c][1,4]benzodiazepine dimers", Synlett, 1112-1114.
9. Antonini, I., Martelli, S. and Polucci, P. (1999) "Bisacridinecarboxamides having antitumor activity. Patent Treaty Cooperation International Apply WO 99 06,372", Chemical Abstracts 130, 168246m.
10. Deady, L.W., Kaye, A.J., Finlay, G.J., Baguley, B.C. and Denny, W.A. (1997) "Synthesis and antitumor properties of N-[2-(dimethylamino)ethyl]carboxamide derivatives of fused tetracyclic quinolines and quinoxalines: a new class of putative topoisomerase inhibitors", Journal of Medicinal Chemistry 40, 2042-2046.
11. Lokey, R.S., Kwok, Y., Guelev, V., Pursell, C.J., Hurley, L.H. and Iverson, B.L. (1997) "A new class of polyintercalating molecules", Journal of the American Chemical Society 119, 7202-7210.
12. Xiao, S., Lin, W., Wang, C. and Yang, M. (2001) "Synthesis and biological evaluation of DNA targeting flexible side-chain substituted β-carboline derivatives", Bioorganic and Medicinal Chemistry Letters 11, 437-441.
13. Olmsted, S.L., Takemori, A.E. and Porthoghese, P.S. (1993) "A remarkable change of opioid receptor selectivity on the attachment of a peptidomimetic κ address element to the δ antagonist. Naltrindole: 5′-[(N2-alkylamidino)methyl]-naltrindole derivatives as a novel class of κ opioid receptor antagonists", Journal of Medicinal Chemistry 36, 179-180.
14. Hu, M.-K. and Lu, C.-F. (2000) "A facile synthesis of bistacrine isosters", Tetrahedron Letters 41, 1815-1818.
15. Carlier, P.R., Du, D.-M., Han, Y.-F., Liu, J., Perola, E., Williams, I.D. and Pang, Y.-P. (2000) "Dimerization of an inactive fragment of huperzine A produces a drug with twice the potency of the natural product* Angewandte Chemie International Edition 39, 1775-1777.
16. Guillou, C., Mary, A., Renko, D.Z., Gras, E. and Thal, C. (2000) "Potent acetylcholinesterase inhibitors: design, synthesis and structure-activity relationships of alkylene linked bisgalanthamine and galanthamine-galanthaminium salts", Bioorganic and Medicinal Chemistry Letters 10, 637-639.
17. Vennerstrom, J.L., Ager, Jr., A.L., Dorn, A., Andersen, S.L., Gerena, L., Ridley, R.G. and Milhous, W.K. (1998) "Bisquinolines 2. Antimalarial N,N-Bis(7-chloroquinolin-4-yl)heteroalkanediamines", Journal of Medicinal Chemistry 41, 4360-4364.
18. 3 dimer as a potential chemical inducer of vitamin D receptor dimerization", Organic Letters 1, 1005-1007.
19. Zhao, H., Neamati, N., Mazumder, A., Sunder, S., Pommier, Y. and Burke, Jr., T.R. (1997) "Arylamide inhibitors of HIV-1 integrase", Journal of Medicinal Chemistry 40, 1186-1194.
20. Pierré, A., Kraus-Berthier, L., Atassi, G., Cros, S., Poupon, M.-F., Lavielle, G., Berlion, M. and Bizzari, J.-P. (1991) "Preclinical antitumor activity of a new vinca alkaloid derivative, S 12363", Cancer Research 51, 2312-2318.
21. β-acyltryptamines", Chemical Communications, 895-897.
22. Charlet-Fagnère, C., Jiang, W-Q. and Laronze, J.-Y. (1999) "Syntheses of large-ring bis-indolic dilactams", Tetrahedron Letters 40, 1685-1688.